The New Way We Work

AI and Ozempic: The two great disruptive technologies of 2023

07.26.2023 - By Fast CompanyPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

AI is poised to upend the music industry, and Fast Company Associate Editor David Salazar joins us to discuss what AI generative music is and how the music industry is combating it.

Antidiabetic medication Ozempic is all over the news these days, but it's not as new as it seems. Beyond the TikTok trends and celebrity shout-outs, it's been used to treat diabetes for years. But now talk of this medication has reached a fever pitch.

Found CEO Sarah Jones Simmer talks about how her company prioritizes comprehensive weight care management, the ongoing discussion about Ozempic, and the very complicated history of weight in this country. Basically, how do we thread the needle between self-acceptance and positive body image and the existing health challenges, like the skyrocketing rates of diabetes?

Then we discuss Barbenheimer because, well, we have to.

More episodes from The New Way We Work